Marimed (MRMD) Long-Term Investments (2015 - 2024)

Marimed (MRMD) has 10 years of Long-Term Investments data on file, last reported at $274000.0 in Q1 2024.

• Long-Term Investments for Q1 2024 came in at $274000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $274000.0 (changed N/A YoY), and the FY2023 annual result was $221000.0, changed N/A from the prior year.
• Long-Term Investments improved to $274000.0 in Q1 2024 per MRMD's latest filing, from $221000.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $2.5 million in Q1 2021 and troughed at $89000.0 in Q2 2023.
• A 5-year average of $1.1 million and a median of $1.0 million in 2020 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2020 and 2021: Long-Term Investments sank 97.1% in 2020, then jumped 103.84% in 2021.
• A 5-year view of Long-Term Investments shows it stood at $1.2 million in 2020, then plunged by 78.47% to $251000.0 in 2021, then surged by 439.04% to $1.4 million in 2022, then slumped by 83.67% to $221000.0 in 2023, then increased by 23.98% to $274000.0 in 2024.
• Business Quant data shows MRMD's Long-Term Investments at $274000.0 in Q1 2024, $221000.0 in Q4 2023, and $164000.0 in Q3 2023.